Efficacy and Adverse Events Associated With Use of OnabotulinumtoxinA for Treatment of Neurogenic Detrusor Overactivity: A Meta-Analysis

  

Stem Cell Therapy in Spinal Cord Injury-Induced Neurogenic Lower Urinary Tract Dysfunction

Yin-Chien Ou, Chi-Chen Huang, Yao-Lin Kao, Pei-Chuan Ho, Kuen-Jer Tsai

Stem Cell Reviews and Reports.2023; 19(6): 1691.     CrossRef

Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment

Agnieszka A. Licow-Kamińska, Sylwester M. Ciećwież, Magdalena Ptak, Dariusz Kotlęga, Agnieszka Brodowska

Toxins.2023; 16(1): 7.     CrossRef

Video-Urodynamic Characteristics and Predictors of Switching from Botulinum Neurotoxin a Injection to Augmentation Enterocystoplasty in Spinal Cord Injury Patients

Chih-Chieh Lin, Hann-Chorng Kuo

Toxins.2022; 14(1): 47.     CrossRef

Neurogenic bladder – concepts and treatment recommendations

José Carlos Truzzi, Fernando Gonçalves de Almeida, Carlos Alberto Sacomani, Joceara Reis, Flávio Eduardo Trigo Rocha

International braz j urol.2022; 48(2): 220.     CrossRef

Neurogenic Bladder Physiology, Pathogenesis, and Management after Spinal Cord Injury

Nathalie Elisabeth Perez, Neha Pradyumna Godbole, Katherine Amin, Raveen Syan, David R. Gater

Journal of Personalized Medicine.2022; 12(6): 968.     CrossRef

Trigonal-Sparing vs. Trigonal-Involved OnabotulinumtoxinA Injection for the Treatment of Overactive Bladder: A Systematic Review and Meta-Analysis

Yuanshan Cui, Tong Cai, Tiantian Dong, Xiaoyi Zhang, Zhongbao Zhou, Youyi Lu, Yong Zhang, Jitao Wu, Zhenli Gao, Yongqiang Wang, Liying Dong

Frontiers in Neurology.2021;[Epub]     CrossRef

Guideline for the management of pre-, intra-, and postpartum care of women with a spinal cord injury

Sue Bertschy, Markus Schmidt, Kai Fiebag, Ute Lange, Simone Kues, Ines Kurze

Spinal Cord.2020; 58(4): 449.     CrossRef